Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations and Comprehensive Loss

v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 24,614 $ 19,057
General and administrative 9,783 7,624
Total operating expenses 34,397 26,681
Operating loss (34,397) (26,681)
Other income, net 1,659 2,267
Total other income, net 1,659 2,267
Loss before income tax expense (32,738) (24,414)
Income tax expense (28) (30)
Net loss (32,766) (24,444)
Other comprehensive income    
Unrealized gain on marketable securities 27 17
Comprehensive loss $ (32,739) $ (24,427)
Basic and diluted net loss per share (in dollars per share) $ (0.7) $ (0.6)
Weighted average shares outstanding – basic and diluted (in shares) 46,980,777 40,404,681